D8 Holdings Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Central, Hong Kong.
IPO Year: 2020
Exchange: NYSE
Website: d8holdingscorp.com
Vicarious Surgical to debut on NYSE as a disruptive next-generation surgical robotics company Approximately $220 million in gross cash proceeds to catalyze advancement of Vicarious Surgical's robotic technology, clinical programs, and strategic business initiatives Combined company to trade on NYSE under ticker symbol "RBOT" Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS))), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, today announced that the shareholders of D8 Holdings Corp. ("D8") (NYSE:DEH, DEH, DEH WS))), have approved the previously announced bus
Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, and D8 Holdings Corp. ("D8") (NYSE:DEH), a special purpose acquisition company, today announced that they have secured $27 million in additional commitments for a private placement of common stock ("PIPE") in support of their business combination transaction, bringing the aggregate amount of PIPE commitments to $142 million, and the total anticipated gross proceeds of the business combination to approximately $487 million (assuming no redemptions). The additional commitments ensure that
WALTHAM, Mass., May 27, 2021 /PRNewswire/ -- Vicarious Surgical Inc. ("Vicarious" or "Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, today announced that Adam Sachs, Co-Founder and Chief Executive Officer of Vicarious Surgical, will participate in a panel discussion on the future of surgical robots at the Surgical Disruptive Technology Summit in Houston, Texas on June 4, 2021. Presentation Details Title: Surgical Robotics: The Next 5 YearsD
CHARLESTOWN, Mass., and HONG KONG, April 15, 2021 /PRNewswire/ -- Vicarious Surgical Inc. ("Vicarious" or "Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, and D8 Holdings Corp. ("D8") (NYSE:DEH), a special purpose acquisition company, today announced that they have entered into a definitive business combination agreement. Upon the closing of this transaction, the combined company will operate as Vicarious Surgical Inc. and will be listed on the New York Stock Exchange ("NYSE") under the new ticker symbol "RBOT".
Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goal of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs The transaction values the combined company at an enterprise value of approximately $1.1 billion and is expected to provide more than $425 million in cash on the balance sheet after closing including a fully committed $115 million PIPE, priced at $10.00 per share PIPE participants include strategic investor, BD (Becton, Dickinson and Company) (NYSE:BDX) - one of the largest global medical technology companies in the world - new institutional investors and existing investors
4/A - Vicarious Surgical Inc. (0001812173) (Issuer)
3/A - Vicarious Surgical Inc. (0001812173) (Issuer)
3 - Vicarious Surgical Inc. (0001812173) (Issuer)
3 - Vicarious Surgical Inc. (0001812173) (Issuer)
4 - Vicarious Surgical Inc. (0001812173) (Issuer)
3 - Vicarious Surgical Inc. (0001812173) (Issuer)
4 - Vicarious Surgical Inc. (0001812173) (Issuer)
3 - Vicarious Surgical Inc. (0001812173) (Issuer)
4 - Vicarious Surgical Inc. (0001812173) (Issuer)
4 - Vicarious Surgical Inc. (0001812173) (Issuer)
8-K - Vicarious Surgical Inc. (0001812173) (Filer)
S-1 - Vicarious Surgical Inc. (0001812173) (Filer)
8-K/A - Vicarious Surgical Inc. (0001812173) (Filer)
8-K - Vicarious Surgical Inc. (0001812173) (Filer)
25-NSE - D8 Holdings Corp. (0001812173) (Subject)
425 - D8 Holdings Corp. (0001812173) (Subject)
8-K - D8 Holdings Corp. (0001812173) (Filer)
S-4MEF - D8 Holdings Corp. (0001812173) (Filer)
425 - D8 Holdings Corp. (0001812173) (Subject)
8-K - D8 Holdings Corp. (0001812173) (Filer)
SC 13G - Vicarious Surgical Inc. (0001812173) (Subject)
SC 13D - Vicarious Surgical Inc. (0001812173) (Subject)
SC 13D - Vicarious Surgical Inc. (0001812173) (Subject)
SC 13D - Vicarious Surgical Inc. (0001812173) (Subject)
SC 13D - Vicarious Surgical Inc. (0001812173) (Subject)
SC 13G - Vicarious Surgical Inc. (0001812173) (Subject)
SC 13G - D8 Holdings Corp. (0001812173) (Subject)
SC 13G - D8 Holdings Corp. (0001812173) (Subject)
SC 13G - D8 Holdings Corp. (0001812173) (Subject)
SC 13G - D8 Holdings Corp. (0001812173) (Subject)